Lataa...
A case of nivolumab-induced cervical lymphadenopathy in a patient with gastric cancer
Nivolumab is a monoclonal antibody targeting programmed cell death-1 (PD-1) that has been recently shown to exhibit clinical efficacy in patients with gastric cancer. However, various degrees of immune-related adverse events (irAEs) have been reported. We report the case of a 71-year-old male patien...
Tallennettuna:
| Julkaisussa: | J Gastrointest Oncol |
|---|---|
| Päätekijät: | , , , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
AME Publishing Company
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8107580/ https://ncbi.nlm.nih.gov/pubmed/34012675 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jgo-20-315 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|